{"entity":{"type":"insider","cik":"0001586939","url":"/insider/0001586939","json_url":"/insider/0001586939.json","name":"Flynn Peter D","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":5,"first":"2014-04-02","last":"2014-06-12","span_basis":"filed_date"},"name_variants":[{"name":"Flynn Peter D","source":"filing","n_filings":5,"first_seen":"2014-04-02","last_seen":"2014-06-12"}],"transactions":[{"id":6328333,"accession":"0001586939-14-000006","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001586939-14-000006","line_url":"/filing/0001586939-14-000006#line-6","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586939","owner_name":"Flynn Peter D","owner_display_name":"Flynn Peter D","owner_url":"/insider/0001586939","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5471.0,"shares_display":"5,471","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":38297.0,"total_display":"38,297.00","total_whole":"38,297","shares_owned_after":4039.0,"shares_owned_after_display":"4,039","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-12","filed_date":"2014-06-12","scope":"insider"},{"id":6328326,"accession":"0001586939-14-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001586939-14-000006","line_url":"/filing/0001586939-14-000006#line-2","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586939","owner_name":"Flynn Peter D","owner_display_name":"Flynn Peter D","owner_url":"/insider/0001586939","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1017.0,"shares_display":"1,017","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":7119.0,"total_display":"7,119.00","total_whole":"7,119","shares_owned_after":4039.0,"shares_owned_after_display":"4,039","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-11","filed_date":"2014-06-12","scope":"insider"},{"id":6271543,"accession":"0001586939-14-000005","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001586939-14-000005","line_url":"/filing/0001586939-14-000005#line-4","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586939","owner_name":"Flynn Peter D","owner_display_name":"Flynn Peter D","owner_url":"/insider/0001586939","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1350.0,"shares_display":"1,350","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":9450.0,"total_display":"9,450.00","total_whole":"9,450","shares_owned_after":4039.0,"shares_owned_after_display":"4,039","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-10","filed_date":"2014-06-11","scope":"insider"},{"id":6271539,"accession":"0001586939-14-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001586939-14-000005","line_url":"/filing/0001586939-14-000005#line-2","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586939","owner_name":"Flynn Peter D","owner_display_name":"Flynn Peter D","owner_url":"/insider/0001586939","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1955.0,"shares_display":"1,955","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":13685.0,"total_display":"13,685.00","total_whole":"13,685","shares_owned_after":4690.0,"shares_owned_after_display":"4,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-09","filed_date":"2014-06-11","scope":"insider"},{"id":6688605,"accession":"0001586939-14-000004","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001586939-14-000004","line_url":"/filing/0001586939-14-000004#line-4","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586939","owner_name":"Flynn Peter D","owner_display_name":"Flynn Peter D","owner_url":"/insider/0001586939","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9793.0,"shares_display":"9,793","price_per_share":7.0662,"price_display":"7.07","price_state":"stated","total_value":69199.2966,"total_display":"69,199.30","total_whole":"69,199","shares_owned_after":5385.0,"shares_owned_after_display":"5,385","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-01","filed_date":"2014-05-05","scope":"insider"},{"id":6509931,"accession":"0001586939-14-000003","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001586939-14-000003","line_url":"/filing/0001586939-14-000003","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586939","owner_name":"Flynn Peter D","owner_display_name":"Flynn Peter D","owner_url":"/insider/0001586939","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Commonm Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5889.0,"shares_display":"5,889","price_per_share":7.999429020207166,"price_display":"8.00","price_state":"stated","total_value":47108.6375,"total_display":"47,108.64","total_whole":"47,109","shares_owned_after":6731.0,"shares_owned_after_display":"6,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-04","filed_date":"2014-04-07","scope":"insider","n_lines":2},{"id":6539839,"accession":"0001586939-14-000002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001586939-14-000002","line_url":"/filing/0001586939-14-000002#line-3","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586939","owner_name":"Flynn Peter D","owner_display_name":"Flynn Peter D","owner_url":"/insider/0001586939","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1346.0,"shares_display":"1,346","price_per_share":9.0465,"price_display":"9.05","price_state":"stated","total_value":12176.589,"total_display":"12,176.59","total_whole":"12,177","shares_owned_after":6731.0,"shares_owned_after_display":"6,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-01","filed_date":"2014-04-02","scope":"insider"},{"id":6539837,"accession":"0001586939-14-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001586939-14-000002","line_url":"/filing/0001586939-14-000002","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586939","owner_name":"Flynn Peter D","owner_display_name":"Flynn Peter D","owner_url":"/insider/0001586939","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2692.0,"shares_display":"2,692","price_per_share":10.15912823179792,"price_display":"10.16","price_state":"stated","total_value":27348.3732,"total_display":"27,348.37","total_whole":"27,348","shares_owned_after":8377.0,"shares_owned_after_display":"8,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-31","filed_date":"2014-04-02","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001434316","name":"FATE THERAPEUTICS INC","url":"/issuer/0001434316","role":"Officer","n_filings":5,"first_seen":"2014-04-02","last_seen":"2014-06-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001586939","retrieved_at":"2026-08-25T02:42:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}